AANA: Research Grants

The AANA Research Grants support clinical and basic science research in arthroscopic surgery, with a funding pool for 2024 reaching $350,000. One project may receive $50,000, while six others can be awarded $25,000 each. Applications are evaluated based on scientific validity, feasibility, clinical relevance, and completion ability. Special consideration is given to innovative surgical techniques and patient-reported outcomes. Travel expenses for study participants may also be considered during grant reviews.

AANA distributes grants for clinical or basic science research in the field of arthroscopic surgery or disorders amenable to arthroscopic treatment. The grant funding pool for 2024 has doubled from recent years and AANA hopes to fund one research project at $50,000 and six projects at $25,000. Fund amounts may vary depending on need and quality of work submitted.
The criteria for evaluation are:

• Scientific ValidityFeasibilityClinical RelevanceAbility to Complete

Eligibility

Only one primary investigator (PI) can be designated on the grant application. However, additional coinvestigators can be added to the application.Comparative, Prospective or Random Studies on:ACL repair and ACL augmentation
Hip capsular management
Shoulder bone loss managementResearch technicians and research assistants will be considered during the grant funding year as a part of the requested award amount.The AANA Research Committee will consider travel expenses for participants in a study during grant reviews (e.g., study participants with disabilities who require ride-sharing services or bus fair to reach a site). Grants are funded one year at a time.Resubmission is required for continuing research.

Ineligibility

Grant funds cannot be used for indirect costs or administrative fees (including salaries).
The exception to this rule is research assistant wages, which will be considered and approved or declined on a case-by-case basis.Travel expenses for the principal investigator (PI) and supporting staff will not be considered.